Scientific partnerships that push boundaries

Person in a lab using scientific equipment

Scientific research relies on sustained effort and collaboration.

We work in partnership with external researchers and organisations to support research activities across multiple stages of development, including areas where the science is complex. Through these partnerships, we apply our expertise to the careful evaluation and progression of scientific work.
style
background-primary-red
additionalPadding
narrow

Lilly advances its pipeline through a combination of internal discovery, collaborations, licensing agreements, and acquisitions.

style
background-primary-red
additionalPadding
narrow
A scientist in a white lab coat and safety glasses looks through a microscope in a laboratory setting
additionalPadding
narrow

Supporting scientific collaboration

Advancing new medicines relies on ongoing research and collaboration across the healthcare and scientific community. We work with external partners to support research efforts across a range of development stages, technologies and therapeutic areas.

Each collaboration is designed to reflect the scientific focus and capabilities of the partner. Through these collaborations, we may provide access to internal expertise, established processes and operational support to help progress research activities where appropriate. Our structured partnership approaches enable collaboration through defined pathways, depending on the needs and stage of the programme.
extra-styles
offset
style
two-col-50-50
Colorful test tubes

Corporate business development

card, titleone-fs-28px, description-fs-14px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-uk, ctanumber-one
We seek the most powerful science for strategic partnerships, licensing and potential acquisitions in our core therapeutic areas. Through Search & Evaluation, Transactions and Alliance & Innovation Management, we operate on the frontiers of medicine development.
Three pipettes with a droplet of solution from one

Lilly Catalyze360

card, titleone-fs-28px, description-fs-14px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-uk, ctanumber-one
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.
Learn more
additionalPadding
narrow
CMAT-06502 May 2026
style
background-primary-red
additionalPadding
narrow